Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TACI antibody

TNFRSF13B Reactivity: Human FACS Host: Mouse Monoclonal 11H3 unconjugated
Catalog No. ABIN1504149
  • Target See all TACI (TNFRSF13B) Antibodies
    TACI (TNFRSF13B) (Tumor Necrosis Factor Receptor Superfamily, Member 13B (TNFRSF13B))
    Reactivity
    • 29
    • 27
    • 6
    • 2
    • 2
    • 2
    • 2
    Human
    Host
    • 31
    • 9
    • 9
    • 5
    Mouse
    Clonality
    • 36
    • 18
    Monoclonal
    Conjugate
    • 29
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This TACI antibody is un-conjugated
    Application
    • 40
    • 19
    • 15
    • 14
    • 14
    • 7
    • 7
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    Flow Cytometry (FACS)
    Specificity
    This antibody reacts with CD267 antigen. Clone 11H3 has an agonistic activity and it doesn't block binding of BAFF to TACI.
    Cross-Reactivity (Details)
    Species reactivity (tested):Human
    Purification
    Protein A agarose
    Clone
    11H3
    Isotype
    IgG2a
    Top Product
    Discover our top product TNFRSF13B Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL
    Buffer
    PBS containing 50 % glycerol, pH 7.2. No preservative is contained.
    Preservative
    Without preservative
  • Target
    TACI (TNFRSF13B) (Tumor Necrosis Factor Receptor Superfamily, Member 13B (TNFRSF13B))
    Alternative Name
    CD267 / TACI (TNFRSF13B Products)
    Background
    CD267, also known as TACI (transmembrane activator and calcium modulator and cyclophilin ligand interactor) or TNFRSF13B, is a member of the tumor necrosis factor (TNF) receptor family that serves as a receptor for B-cell activating factor of the TNF family (BAFF/CD257) and as a proliferation-inducing ligand (APRIL/CD256). BAFF and APRIL bind both TACI and BCMA (B cell maturation Ag/CD269), with BAFF additionally and exclusivel y binding the BAFF receptor (BAFF-R/CD268) while APRIL can also bind to heparin sulfate proteoglycan s (HSPG). TACI is expressed on B cells and activated T cells. BC MA is exclusively expressed on B cells, whereas BAFF-R is expressed mainly on B cells but also on T cells. It is reported that mutations of CD267/TACI are showed in patients with IgA deficiency and common variable immunodeficiency (CVID). Sakurai et al ., reported that TACI positively regulated APRIL-induced IgA production in collaboration with HSPG and TACI negatively regulated BAFF-induced B-cell proliferation and production of IgA and IgG.Synonyms: TNFRSF13B, Transmembrane activator and CAML interactor, Tumor necrosis factor receptor superfamily member 13B
    Gene ID
    23495
You are here:
Support